188 related articles for article (PubMed ID: 34934614)
1. HDAC inhibitors stimulate LIFR when it is repressed by hypoxia or PTHrP in breast cancer.
Edwards CM; Clements ME; Vecchi LA; Johnson JA; Johnson RW
J Bone Oncol; 2021 Dec; 31():100407. PubMed ID: 34934614
[TBL] [Abstract][Full Text] [Related]
2. HDAC inhibitors induce LIFR expression and promote a dormancy phenotype in breast cancer.
Clements ME; Holtslander L; Edwards C; Todd V; Dooyema SDR; Bullock K; Bergdorf K; Zahnow CA; Connolly RM; Johnson RW
Oncogene; 2021 Aug; 40(34):5314-5326. PubMed ID: 34247191
[TBL] [Abstract][Full Text] [Related]
3. Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow.
Johnson RW; Finger EC; Olcina MM; Vilalta M; Aguilera T; Miao Y; Merkel AR; Johnson JR; Sterling JA; Wu JY; Giaccia AJ
Nat Cell Biol; 2016 Oct; 18(10):1078-1089. PubMed ID: 27642788
[TBL] [Abstract][Full Text] [Related]
4. Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer.
Zeng H; Qu J; Jin N; Xu J; Lin C; Chen Y; Yang X; He X; Tang S; Lan X; Yang X; Chen Z; Huang M; Ding J; Geng M
Cancer Cell; 2016 Sep; 30(3):459-473. PubMed ID: 27622335
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone-related protein in breast cancer bone metastasis.
Johnson RW; Rhoades J; Martin TJ
Vitam Horm; 2022; 120():215-230. PubMed ID: 35953110
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid Hormone-Related Protein Negatively Regulates Tumor Cell Dormancy Genes in a PTHR1/Cyclic AMP-Independent Manner.
Johnson RW; Sun Y; Ho PWM; Chan ASM; Johnson JA; Pavlos NJ; Sims NA; Martin TJ
Front Endocrinol (Lausanne); 2018; 9():241. PubMed ID: 29867773
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of hypoxia-related responses by novel antitumor histone deacetylase inhibitors in MDAMB231 breast cancer cells.
Naldini A; Filippi I; Cini E; Rodriquez M; Carraro F; Taddei M
Anticancer Agents Med Chem; 2012 May; 12(4):407-13. PubMed ID: 22043993
[TBL] [Abstract][Full Text] [Related]
8. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
9. PTHrP intracrine actions divergently influence breast cancer growth through p27 and LIFR.
Edwards CM; Kane JF; Smith JA; Grant DM; Johnson JA; Diaz MAH; Vecchi LA; Bracey KM; Omokehinde TN; Fontana JR; Karno BA; Scott HT; Vogel CJ; Lowery JW; Martin TJ; Johnson RW
Breast Cancer Res; 2024 Feb; 26(1):34. PubMed ID: 38409028
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling.
Johnson RW; Nguyen MP; Padalecki SS; Grubbs BG; Merkel AR; Oyajobi BO; Matrisian LM; Mundy GR; Sterling JA
Cancer Res; 2011 Feb; 71(3):822-31. PubMed ID: 21189326
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.
Guise TA; Yin JJ; Taylor SD; Kumagai Y; Dallas M; Boyce BF; Yoneda T; Mundy GR
J Clin Invest; 1996 Oct; 98(7):1544-9. PubMed ID: 8833902
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter.
Lee KJ; Lee KY; Lee YM
Biochim Biophys Acta; 2010 May; 1803(5):608-16. PubMed ID: 20080132
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.
Shimo T; Kubota S; Yoshioka N; Ibaragi S; Isowa S; Eguchi T; Sasaki A; Takigawa M
J Bone Miner Res; 2006 Jul; 21(7):1045-59. PubMed ID: 16813525
[TBL] [Abstract][Full Text] [Related]
14. The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells.
Sterling JA; Oyajobi BO; Grubbs B; Padalecki SS; Munoz SA; Gupta A; Story B; Zhao M; Mundy GR
Cancer Res; 2006 Aug; 66(15):7548-53. PubMed ID: 16885353
[TBL] [Abstract][Full Text] [Related]
15. Loss of epigenetic Kruppel-like factor 4 histone deacetylase (KLF-4-HDAC)-mediated transcriptional suppression is crucial in increasing vascular endothelial growth factor (VEGF) expression in breast cancer.
Ray A; Alalem M; Ray BK
J Biol Chem; 2013 Sep; 288(38):27232-27242. PubMed ID: 23926105
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.
Lapierre M; Linares A; Dalvai M; Duraffourd C; Bonnet S; Boulahtouf A; Rodriguez C; Jalaguier S; Assou S; Orsetti B; Balaguer P; Maudelonde T; Blache P; Bystricky K; Boulle N; Cavaillès V
Oncotarget; 2016 Apr; 7(15):19693-708. PubMed ID: 26930713
[TBL] [Abstract][Full Text] [Related]
17. Suppression of HIF-1α by Valproic Acid Sustains Self-Renewal of Mouse Embryonic Stem Cells under Hypoxia In Vitro.
Lee HJ; Kim KW
Biomol Ther (Seoul); 2012 May; 20(3):280-5. PubMed ID: 24130924
[TBL] [Abstract][Full Text] [Related]
18. Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer.
Cui XY; Tinholt M; Stavik B; Dahm AE; Kanse S; Jin Y; Seidl S; Sahlberg KK; Iversen N; Skretting G; Sandset PM
J Thromb Haemost; 2016 Feb; 14(2):387-96. PubMed ID: 26598923
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia induces PTHrP gene transcription in human cancer cells through the HIF-2α.
Manisterski M; Golan M; Amir S; Weisman Y; Mabjeesh NJ
Cell Cycle; 2010 Sep; 9(18):3723-9. PubMed ID: 20890122
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase CK2 is a key activator of histone deacetylase in hypoxia-associated tumors.
Pluemsampant S; Safronova OS; Nakahama K; Morita I
Int J Cancer; 2008 Jan; 122(2):333-41. PubMed ID: 17935135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
